STOCK TITAN

Merger pays ProAssurance (NYSE: PRA) CEO $25 per share for all equity

Filing Impact
(Very High)
Filing Sentiment
(Neutral)
Form Type
4

Rhea-AI Filing Summary

PROASSURANCE CORP President & CEO Rand Edward Lewis Jr reported dispositions in connection with the closing of the company’s merger with The Doctors Company. On June 26, 2026, all 293,945 shares of common stock he held were cancelled and converted into the right to receive $25.00 per share in cash under the merger terms.

The filing also shows 47,529, 29,665 and 95,714 outstanding restricted stock units, each representing one share of common stock, were cancelled at the effective time of the merger. These vested and entitled him to cash equal to the number of underlying shares multiplied by the same $25.00 per share merger consideration. Following these transactions, no common stock or RSUs are shown as beneficially owned.

Positive

  • Merger consideration of $25.00 per share in cash was paid for all outstanding common shares, including the CEO’s holdings, confirming a full cash exit for equity holders at that price.

Negative

  • None.

Insights

CEO equity fully cashed out via $25 per share merger.

The disclosure shows the ProAssurance CEO’s equity converting entirely into cash when the merger with The Doctors Company closed. Common shares and unvested restricted stock units were not sold on the market but cancelled for a fixed cash amount of $25.00 per share.

This clarifies how senior management was treated economically in the transaction and confirms no continuing equity stake is reported after closing. It reinforces that all outstanding common shares and eligible RSUs participated in the same merger consideration, aligning executives with other shareholders on the June 26, 2026 effective time.

Insider Rand Edward Lewis Jr
Role President & CEO
Type Security Shares Price Value
Disposition Restricted Stock Units 95,714 $0.00 --
Disposition Restricted Stock Units 29,665 $0.00 --
Disposition Restricted Stock Units 47,529 $0.00 --
Disposition Common Stock 293,945 $25.00 $7.35M
Holdings After Transaction: Restricted Stock Units — 0 shares (Direct, null); Common Stock — 0 shares (Direct, null)
Footnotes (1)
  1. On June 26, 2026, pursuant to that certain Agreement and Plan of Merger, dated as of March 19, 2025 (the "Merger Agreement"), among ProAssurance Corporation (the "Issuer"), The Doctors Company ("Parent") and Jackson Acquisition Corporation, a wholly owned subsidiary of Parent ("Merger Sub"), Merger Sub merged with and into the Issuer (the "Merger"), with the Issuer surviving the Merger as a wholly owned subsidiary of Parent. Reflects an adjustment to the number of shares beneficially owned after a reconciliation of the Issuer's records. At the effective time of the Merger (the "Effective Time"), upon the terms and subject to the conditions set forth in the Merger Agreement, each share of the Issuer's common stock, par value $0.01 per share (the "Common Stock") that was issued and outstanding immediately prior to the Effective Time (other than certain excluded shares) was cancelled and converted into the right to receive $25.00 per share in cash, without interest, and subject to any applicable withholding taxes (the "Merger Consideration"). Each restricted stock unit ("RSU") represents a contingent right to receive one share of Common Stock. Represents outstanding unvested RSUs (other than certain excluded RSUs, which were forfeited at the Effective Time in accordance with their terms). At the Effective Time, upon the terms and subject to the conditions set forth in the Merger Agreement, the outstanding, unvested time-based and performance-based RSUs (other than the excluded RSUs) automatically and immediately vested and were cancelled and entitled the holder to receive an amount in cash, without interest, equal to the product of (a) the total number of shares of Common Stock subject to the RSUs immediately prior to the Effective Time, multiplied by (b) the Merger Consideration.
Common shares disposed 293,945 shares Disposition to issuer at merger effective time
Merger consideration per share $25.00 per share Cash paid for each share of common stock
RSUs block 1 47,529 RSUs Outstanding unvested RSUs vested and cancelled for cash
RSUs block 2 29,665 RSUs Outstanding unvested RSUs vested and cancelled for cash
RSUs block 3 95,714 RSUs Outstanding unvested RSUs vested and cancelled for cash
Shares after transaction 0 shares Common stock beneficially owned following merger-related disposition
Agreement and Plan of Merger financial
"On June 26, 2026, pursuant to that certain Agreement and Plan of Merger, dated as of March 19, 2025..."
An Agreement and Plan of Merger is a formal document where two companies agree to combine into one, outlining how the process will happen. It’s like a step-by-step plan for merging, and it matters because it shows both sides have agreed on the details before the official transition takes place.
Merger Consideration financial
"was cancelled and converted into the right to receive $25.00 per share in cash... (the "Merger Consideration")."
Merger consideration is the total payment a company or buyer offers to shareholders of a target company in exchange for combining the two businesses, and can include cash, shares in the surviving company, debt assumption, or a mix of these. Investors care because the form and amount affect the deal’s value, tax consequences, immediate cash received versus future ownership, and the risk and upside of holding new shares — similar to choosing between cash now or stock that could grow later.
Effective Time financial
"At the effective time of the Merger (the "Effective Time"), upon the terms and subject to the conditions..."
The exact clock time when a regulatory filing, approval, or corporate action formally becomes legally active; from that moment the change is binding and can be acted on. Investors care because the effective time marks when ownership, rights, trading rules, or new securities take effect — like a light switch turning on a contract or transaction — which determines when risks, benefits and market reactions begin.
restricted stock unit ("RSU") financial
"Each restricted stock unit ("RSU") represents a contingent right to receive one share of Common Stock."
time-based and performance-based RSUs financial
"the outstanding, unvested time-based and performance-based RSUs... automatically and immediately vested and were cancelled..."
See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
Learn about SEC filing dates
SEC Form 4
FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Estimated average burden
hours per response:0.5
X
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Rand Edward Lewis Jr

(Last)(First)(Middle)
C/OPROASSURANCE CORPORATION
100 BROOKWOOD PLACE

(Street)
BIRMINGHAM ALABAMA 35209

(City)(State)(Zip)

UNITED STATES

(Country)
2. Issuer Name and Ticker or Trading Symbol
PROASSURANCE CORP [ PRA ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
XDirector10% Owner
XOfficer (give title below)Other (specify below)
President & CEO
2a. Foreign Trading Symbol
3. Date of Earliest Transaction (Month/Day/Year)
06/26/2026
6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeVAmount(A) or (D)Price
Common Stock06/26/2026D(1)293,945(2)D$25(3)0D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Restricted Stock Units(4)06/26/2026D(1)95,714 (5) (5)Common Stock95,714(5)0D
Restricted Stock Units(4)06/26/2026D(1)29,665 (5) (5)Common Stock29,665(5)0D
Restricted Stock Units(4)06/26/2026D(1)47,529 (5) (5)Common Stock47,529(5)0D
Explanation of Responses:
1. On June 26, 2026, pursuant to that certain Agreement and Plan of Merger, dated as of March 19, 2025 (the "Merger Agreement"), among ProAssurance Corporation (the "Issuer"), The Doctors Company ("Parent") and Jackson Acquisition Corporation, a wholly owned subsidiary of Parent ("Merger Sub"), Merger Sub merged with and into the Issuer (the "Merger"), with the Issuer surviving the Merger as a wholly owned subsidiary of Parent.
2. Reflects an adjustment to the number of shares beneficially owned after a reconciliation of the Issuer's records.
3. At the effective time of the Merger (the "Effective Time"), upon the terms and subject to the conditions set forth in the Merger Agreement, each share of the Issuer's common stock, par value $0.01 per share (the "Common Stock") that was issued and outstanding immediately prior to the Effective Time (other than certain excluded shares) was cancelled and converted into the right to receive $25.00 per share in cash, without interest, and subject to any applicable withholding taxes (the "Merger Consideration").
4. Each restricted stock unit ("RSU") represents a contingent right to receive one share of Common Stock.
5. Represents outstanding unvested RSUs (other than certain excluded RSUs, which were forfeited at the Effective Time in accordance with their terms). At the Effective Time, upon the terms and subject to the conditions set forth in the Merger Agreement, the outstanding, unvested time-based and performance-based RSUs (other than the excluded RSUs) automatically and immediately vested and were cancelled and entitled the holder to receive an amount in cash, without interest, equal to the product of (a) the total number of shares of Common Stock subject to the RSUs immediately prior to the Effective Time, multiplied by (b) the Merger Consideration.
Remarks:
Lee M. Pope, POA for the Reporting Person06/26/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

FAQ

What did ProAssurance (PRA) CEO Rand Edward Lewis Jr report in this Form 4?

He reported that all his ProAssurance common shares and outstanding restricted stock units were cancelled in the merger and converted into cash. Each share of common stock and eligible RSU received $25.00 per share in cash under the merger agreement.

How many ProAssurance common shares were disposed of by the CEO in the merger?

The Form 4 shows 293,945 shares of common stock were disposed of in a transaction coded as a disposition to the issuer. These shares were cancelled at the merger’s effective time and converted into the right to receive $25.00 per share in cash.

What happened to the ProAssurance (PRA) restricted stock units held by the CEO?

Outstanding unvested restricted stock units automatically vested at the merger’s effective time and were cancelled. The filing lists blocks of 47,529, 29,665 and 95,714 RSUs, each entitling the holder to cash equal to shares multiplied by the $25.00 merger consideration.

What cash consideration did ProAssurance shareholders, including the CEO, receive in the merger?

Each issued and outstanding share of ProAssurance common stock immediately before the effective time was converted into the right to receive $25.00 per share in cash, without interest and subject to applicable withholding taxes, as defined as the merger consideration.

Does the ProAssurance CEO retain any shares after these Form 4 transactions?

The Form 4 reports zero shares of common stock and zero restricted stock units beneficially owned following the merger-related dispositions. All reported equity interests were cancelled at closing and converted into the right to receive the specified cash merger consideration instead.